Webinar- COVID-19 & Malignant Hyperthermia Preparedness

April 30, 2020
3:00 PM - 4:00 PM
 Add to Calendar

Online Webinar
518-530-1840 Passcode - 163827363

Venue website

The COVID-19 crisis has resulted in increased acuity and census in inpatient facilities, changes in the number and types of patients seen in the ambulatory surgery setting and a potential increase in the use of malignant hyperthermia triggering agents.  All of these factors impact the risk of malignant hyperthermia.  In this session we will discuss malignant hyperthermia preparedness in the context of our current healthcare environment. 

Presented by:

Mike Greenberg, MD

Vice President, Medical Affairs

Eagle Pharmaceuticals, Inc.

Mike Greenberg, MD, an emergency physician by training, is the Vice President of Medical Affairs at Eagle Pharmaceuticals where he focuses heavily on hyperthermic/hypermetabolic diseases including malignant hyperthermia. In addition to his experience as an emergency physician and medical affairs
professional, Dr. Greenberg has also worked with the Federal Agency for Healthcare Research and Quality (AHRQ) to raise awareness of comparative effectiveness research, and as acted as a consultant to teams focusing on Risk Evaluation and Mitigation Strategies (REMS) and Drug Safety Communications at the FDA Center for Drug Evaluation and Research (CDER). Mike earned his medical degree at the State University of New York Upstate Medical University and completed a residency in Emergency Medicine at the University of Massachusetts.

This Webinar has been approved for one hour of genearl CE by the Florida Boad of Nursing:

CE Broker Tracking #: 20-697041



$0.00 Member Registration

$0.00 Member Registration